At the yearly ReAct Africa Conference in Zambia in July, the Director General of the Zambia National Public Health Institute (ZNPHI) Professor Roma Chilengi, launched the Zambia Strategic Program for Antimicrobial Stewardship (ZASPARS). The program is an adaptation of the Swedish strategic programme against antibiotic resistance (STRAMA) which has led to a significant reduction of the inappropriate use of antibiotics in Sweden since its introduction in 1995.
New approach brings in all stakeholders under one umbrella in Zambia
“ZASPARS is will be at the heart of Zambia’s AMR National Action Plan and bring all of us in under a One Health umbrella. It will be a platform for learning and sharing of best practices and advocacy work between clinicians, microbiologists, infectious diseases physicians, pharmacists, veterinarians, clinical officers, environmentalists, and community members.”
says Professor Roma Chilengi
ZASPARS include key components of the Swedish STRAMA model such as:
- information and training of physicians
- monitoring, analysis and feedback of antibiotic use and resistance
- treatment recommendations
Recently a full time AMR Focal Point for Zambia was appointed, who will engage in this work. This is an upscale compared to earlier. Other key stakeholders are: professional bodies and societies, Zambia Medicines Regulatory Agency (ZAMRA), patient care groups and non-governmental organizations.
Professor Otto Cars, who initiated the Strama model in Sweden says:
“I am happy that Strama Sweden has inspired the work in Zambia. And I am convinced that ZASPARS will play an important role – by providing a platform for collaboration among key actors in the country – to manage antibiotic resistance.”
Provincial and district committees to be formed
The ZASPARS programme will be led by the country’s Antimicrobial Resistance Coordinating Committee (AMRCC) under the Zambia National Public Health Institute (ZNPHI). Following the successful model of Swedish STRAMA, provincial and district committees will be formed to engage an all-inclusive and supportive program for antimicrobial stewardship.
Mirfin Mpundu, Director ReAct Africa says:
“The launch of ZASPARS after STRAMA is a major milestone. ZASPARS will play an integral role in realizing Zambia’s AMR National Action Plan goals through institutional strengthening in antimicrobial stewardship, developing and utilization of evidence-based treatment guidelines, capacity building and a whole of society engagement. This north-to-south and south-to-north learning is essential.”
ReAct Africa will take a leading role in its inception and ReAct Europe will provide continuous support on the adaptation of the STRAMA approach. The start-up of this stewardship model in Zambia was initiated with targeted support from ReAct and a very strong engagement from key stakeholders in Zambia. Zambia will play a central role in addressing antibiotic resistance on the African continent.
More from "2022"
- 15 things that need to happen in 2023 – for a robust response on antibiotic resistance!
- 7.7 million people die from bacterial infections every year
- ReAct highlights during World Antimicrobial Awareness Week 2022
- Awareness walk in Lusaka, Zambia
- ReAct Asia Pacific: Competitions, webinars, social media campaigns and new Indonesian declaration on AMR
- Otto Cars awarded Research!Sweden’s Honorary Award
- Innovate4Health: 16 finalists from 12 countries!
- Otto Cars has dedicated his life to the fight against antibiotic resistance
- ReAct activities for World Antimicrobial Awareness Week 2022
- ReAct Asia Pacific: Antibiotic Smart Communities as a way forward
- Webinar ReAct Asia Pacific! Moving towards an Antibiotic Smart Community – the use of a novel indicator framework
- Join ReAct Latin America Meeting: Empowered Communities!
- The impact of antibiotic resistance on cancer treatment, especially in low-and middle-income countries, and the way forward
- Sweden: Pernilla’s 8-day old daughter died from sepsis – caused by resistant bacteria Klebsiella
- Five challenges that governments need to address in resolving the stagnation in antibiotic development
- The monkeypox outbreak: Need for antibiotic stewardship?
- Key takeaways from the ReAct Africa and South Centre Conference
- New ReAct Europe and EPHA position paper on EU incentives for new antibiotics development
- Launch of a new approach to antimicrobial stewardship in Zambia
- Time to register for the annual ReAct Africa and South Centre conference!
- Innovate4Health 2022: Call for student team applications!
- “Need to address the paradox of hospitals spreading disease” says new WHO report
- 5 takeaways from AMR Stockholm+50 event
- Student Tehseen Contractor
- ReAct Latin America: call to governments on the use of antimicrobials in intensive animal husbandry
- Join ReAct Stockholm+50 associated event! Global AMR response – What needs to be done?
- New opportunities for global action on AMR?
- Public hearings on elements to be included in a new international instrument on pandemic preparedness & response
- Policy briefing on WHO GAP AMR: 8 pillars of action to address global solutions to AMR
- India: State Action Plans on AMR in focus at stakeholder colloquium
- The silence is killing us – time to listen to the facts
- Access to clean water – a fairly inexpensive way to avoid infections
- Anna Sjöblom new Director ReAct Europe
- Dr. Hari Paraton: Drug resistance bacteria threatens lives of mothers and newborns
- Antibiotic resistance claims more than 1,2 million lives a year, says new large study
- Artificial intelligence – the future of antibiotic resistance prevention?